AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
68.95
+1.38 (2.04%)
At close: May 12, 2025, 4:00 PM
68.88
-0.07 (-0.10%)
After-hours: May 12, 2025, 7:23 PM EDT
AstraZeneca Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AstraZeneca stock have an average target of 92.33, with a low estimate of 85 and a high estimate of 97. The average target predicts an increase of 33.91% from the current stock price of 68.95.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for AstraZeneca stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 1 | 1 | 1 | 0 |
| Hold | 4 | 4 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 7 | 7 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 13, 2025 |
| UBS | UBS | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Nov 20, 2024 |
| Erste Group | Erste Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 11, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $95 | Strong Buy | Maintains | $90 → $95 | +37.78% | Aug 12, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +23.28% | May 30, 2024 |
Financial Forecast
Revenue This Year
59.08B
from 54.07B
Increased by 9.27%
Revenue Next Year
62.64B
from 59.08B
Increased by 6.02%
EPS This Year
4.62
from 4.50
Increased by 2.61%
EPS Next Year
5.24
from 4.62
Increased by 13.40%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 62.6B | 69.8B | 76.4B | ||
| Avg | 59.1B | 62.6B | 66.2B | ||
| Low | 52.7B | 54.8B | 57.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.8% | 18.1% | 21.9% | ||
| Avg | 9.3% | 6.0% | 5.6% | ||
| Low | -2.5% | -7.3% | -8.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.18 | 6.15 | 7.03 | ||
| Avg | 4.62 | 5.24 | 5.75 | ||
| Low | 3.74 | 4.35 | 4.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.0% | 33.1% | 34.3% | ||
| Avg | 2.6% | 13.4% | 9.8% | ||
| Low | -16.9% | -5.9% | -10.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.